<?xml version="1.0"?>

<document>
	<title>Cystic fibrosis: comparison of two mucolytic drugs for inhalation
   treatment (acetylcysteine and arginine hydrochloride).</title>

	<author>Dietzsch-H-J.</author>
	<author>Gottschalk-B.</author>
	<author>Heyne-K.</author>
	<author>Leupoid-W.</author>
	<author>Wunderlich-P.</author>

	<source>Pediatrics. 1975 Jan. 55(1). P 96-100.</source>

	<abstract>Clinical, bronchoscopic, spirographic, scintigraphic, and chemical
   analyses were done in 24 children with cystic fibrosis to assess the
   mucolytic effects of acetylcysteine inhalations versus L-arginine
   hydrochloride aerosols. The latter drug is less active than
   acetylcysteine and should not be used to treat children with cystic
   fibrosis.</abstract>

	<majorsubject>ACETYLCYSTEINE: ad</majorsubject>
	<majorsubject>ARGININE: ad</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: dt</majorsubject>
	<majorsubject>EXPECTORANTS: ad</majorsubject>

	<minorsubject>ACETYLCYSTEINE: tu</minorsubject>
	<minorsubject>AEROSOLS</minorsubject>
	<minorsubject>ARGININE: tu</minorsubject>
	<minorsubject>BRONCHOSCOPY</minorsubject>
	<minorsubject>CARBON-DIOXIDE: bl</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>COUGH</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: pp</minorsubject>
	<minorsubject>DRUG-EVALUATION</minorsubject>
	<minorsubject>EXPECTORANTS: tu</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>MUCUS: se</minorsubject>
	<minorsubject>OXYGEN: bl</minorsubject>
	<minorsubject>RADIONUCLIDE-IMAGING</minorsubject>
	<minorsubject>RESPIRATION</minorsubject>
	<minorsubject>RESPIRATORY-FUNCTION-TESTS</minorsubject>
	<minorsubject>SPIROMETRY</minorsubject>
	<minorsubject>SPUTUM: mi</minorsubject>

	<reference>001   WEBB WR               POSTGRAD MED                    36   449 964</reference>
	<reference>002   DENTON R              AM REV RESPIR DIS               95   643 967</reference>
	<reference>003   DIETZSCH HJ           BRONCHES                        20   383 970</reference>
	<reference>004   DIETZSCH HJ           Z ERKR ATMUNGSORGANE           134   445 971</reference>
	<reference>005   DIETZSCH HJ           MEDICAMENTUM                    13   299 972</reference>
	<reference>006   GOTTSCHALK B          DTSCH GESUNDHEITSW              25   700 970</reference>
	<reference>007   GOTTSCHALK B          DTSCH GESUNDHEITSW              27  1121 972</reference>
	<reference>008   HUANG NN              GUIDE TO DRUG THERAPY IN PATI            972</reference>
	<reference>009   MILLER WF             ARCH INTERN MED                131   148 973</reference>
	<reference>010   REAS HW               J PEDIATR                       65   542 964</reference>
	<reference>011   SHEFFNER AL           BIOCHEM PHARMACOL               15  1523 966</reference>
	<reference>012   WEBB WR               J THORAC CARDIOVASC SURG        44   330 962</reference>
	<reference>013   WEBB WR               CLIN MED                        71  1531 964</reference>
	<reference>014   LEUPOLD W             DTSCH GESUNDHEITSW              25  1400 970</reference>
	<reference>015   MATTHEWS LW           MINN MED                        52  1483 969</reference>
	<reference>016   DIETZSCH HJ           DTSCH GESUNDHEITSW              28   842 973</reference>
	<reference>017   SOLOMONS CC           PEDIATRICS                      47   384 971</reference>
	<reference>018   DIETZSCH HJ           PAEDIATR GRENZGEB                6   195 967</reference>

	<citation>1   DIETZSCH HJ           PEDIATRICS                      57   166 976</citation>
	<citation>2   SOLOMONS C            PEDIATRICS                      57   166 976</citation>
	<citation>3   RICHARDSON PS         PHARMACOL THER (B)               3   441 978</citation>
	<citation>4   TABACHNIK E           AM REV RESPIR DIS              122    97 980</citation>
	<citation>5   WANNER A              AM REV RESPIR DIS              122    79 980</citation>

</document>
